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Neutrophils mediate early 
cerebral cortical hypoperfusion in 
a murine model of subarachnoid 
haemorrhage
Axel Neulen  1, tobias pantel1, Michael Kosterhon1, Andreas Kramer1, sascha Kunath2, 
Maximilian petermeyer1, Bernd Moosmann2, Johannes Lotz3, sven R. Kantelhardt1, 
Florian Ringel1 & serge C. thal  4
Cerebral hypoperfusion in the first hours after subarachnoid haemorrhage (SAH) is a major determinant 
of poor neurological outcome. However, the underlying pathophysiology is only partly understood. 
Here we induced neutropenia in C57BL/6N mice by anti-Ly6G antibody injection, induced SAH by 
endovascular filament perforation, and analysed cerebral cortical perfusion with laser SPECKLE 
contrast imaging to investigate the role of neutrophils in mediating cerebral hypoperfusion during 
the first 24 h post-SAH. SAH induction significantly increased the intracranial pressure (ICP), and 
significantly reduced the cerebral perfusion pressure (CPP). At 3 h after SAH, ICP had returned to 
baseline and CPP was similar between SAH and sham mice. However, in SAH mice with normal 
neutrophil counts cortical hypoperfusion persisted. Conversely, despite similar Cpp, cortical perfusion 
was significantly higher at 3 h after SAH in mice with neutropenia. The levels of 8-iso-prostaglandin-
F2α in the subarachnoid haematoma increased significantly at 3 h after SAH in animals with normal 
neutrophil counts indicating oxidative stress, which was not the case in neutropenic SAH animals. 
these results suggest that neutrophils are important mediators of cortical hypoperfusion and oxidative 
stress early after SAH. Targeting neutrophil function and neutrophil-induced oxidative stress could be a 
promising new approach to mitigate cerebral hypoperfusion early after SAH.
Aneurysmal subarachnoid haemorrhage (SAH) is one of the most common forms of haemorrhagic stroke1–3. 
Frequently the neurological outcome is poor, especially in cases presenting with coma and focal deficits. 
Morbidity and mortality may arise from the haemorrhage itself, which causes a dramatic increase in intracranial 
pressure (ICP). Even in patients surviving early ICP elevation, however, brain damage develops in two distinct 
phases termed early brain injury (EBI)4,5 and delayed cerebral ischemia (DCI)4,6. Early brain injury is caused by 
transient global cerebral ischemia during the haemorrhage and by toxic processes induced by the subarachnoid 
haematoma4–6. Conversely, DCI occurs days and weeks after SAH from the combined effects of vasospasm in 
large intracranial vessels and microvessels, microthrombosis and ischemia related to cortical spreading depres-
sion, and proinflammatory processes triggered by EBI4,6,7.
While major research efforts over the past few decades have focused on DCI (reviewed in6), recent clinical 
research data indicate that the degree of cerebral hypoperfusion during the first hours after SAH determines 
the severity of EBI, the occurrence of DCI, and the neurological outcome4,8–14. These findings suggest that 
EBI-associated processes causing cerebral hypoperfusion early after SAH are critical determinants of DCI severity 
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and neurological outcome. A more complete understanding of processes leading to early cerebral hypoperfusion 
following SAH could therefore facilitate the development of new therapeutic strategies.
Blood in the subarachnoid space and subsequent haemoglobin degradation trigger an inflammatory cas-
cade7,15. The central role of leukocyte-dependent inflammation in the etiology of delayed cerebral vasospasm was 
demonstrated by results showing attenuated delayed vasospasm following experimental SAH by blocking leuko-
cyte extravasation with antibodies directed against intercellular adhesion molecule 1, cluster of differentiation 11 
(CD11), or CD1816,17. Furthermore, induction of neutropenia by injection of an anti-Ly6G antibody attenuated 
delayed cerebral vasospasm18 and improved neurological outcome19. In line with these experimental data, a high 
percentage of neutrophils in human cerebrospinal fluid (CSF) samples on day 3 post-SAH was associated with 
development of cerebral vasospasm and markers of oxidative stress were elevated in CSF samples from SAH 
patients20.
However, neutrophils accumulate at the site of infection within minutes21–23. Similarly, Friedrich et al.24 
reported that neutrophils accumulate in cerebral microvessels and infiltrate brain parenchyma within 10 min after 
induction of SAH in rats, while Yang et al.25 observed leukocyte adhesion to postcapillary venules within 10 min 
after SAH in an in vivo microscopy study of mice. These findings indicate that inflammatory processes induced 
by rapid neutrophil accumulation at the site of the subarachnoid haematoma may contribute to early cerebral 
hypoperfusion as well as delayed cerebral vasospasm.
The present study was designed to examine whether neutrophil-mediated inflammation contributes to early 
cerebral cortical hypoperfusion in the hours following SAH. To this end, we compared regional cerebral perfusion 
and oxidative stress at the haemorrhage site between model mice with a normal neutrophil count and those with 
neutropenia induced by anti-Ly6G antibody during the first 24 hours after SAH.
Materials and Methods
ethics, animals, and housing conditions. The animal experiments were approved by the responsible 
animal care committee (Landesuntersuchungsamt Rheinland-Pfalz) and conducted in accordance with the 
German Animal Welfare Act (TierSchG). All applicable international, national, and institutional guidelines for 
the care and use of animals were followed.
Male C57BL/6N mice (Janvier, Saint-Berthevin Cedex, France; age, 11–12 weeks) were used for all exper-
iments. The mice were housed under controlled environmental conditions (12-h light–dark cycle, 23 ± 1 °C, 
55% ± 5% relative humidity) with free access to water and food (Altromin, Lage, Germany). As a general marker 
of well-being, body weight was determined daily during the experiments.
Quantitative data collection was conducted in a blinded fashion (animals and sample tubes were marked by 
numbers, without any identifiers of group allocation).
Randomisation, and study design. Sixty-six animals were randomised to two groups: 30 animals were 
assigned for imaging of cerebral perfusion and 36 animals for biochemical analysis. Within each group, subsets 
were randomly assigned to receive experimental SAH or sham surgery and neutropenia induction or control 
treatment (described below). In animals assigned to the cerebral perfusion group, serial measurements of cere-
bral cortical perfusion were performed before the surgical procedure and 15 min, 3 h, and 24 h after induction of 
SAH or sham surgery together with determination of ICP. The mean arterial blood pressure was also determined 
daily in the cerebral perfusion group during the experiments using a non-invasive system (Coda mouse tail-cuff 
system; Kent-Scientific, Torrington, CT, USA). In animals assigned to the biochemistry group, cerebral perfusion 
and blood pressure were not analysed. Rather, transcardiac perfusion was performed 15 min, 3 h, or 24 h after 
induction of SAH to analyse the subarachnoid haematoma as described below.
In the cerebral perfusion group, 15 animals were randomised to receive neutropenia induction (described 
below) and 15 to the matched control subgroup. In both subgroups, six animals were randomised to sham surgery 
and nine to SAH induction (described below). Of the 36 animals assigned to the group for biochemical analysis, 
18 were randomised to the control subgroup and 18 to neutropenia induction. In the biochemical analysis group, 
all 36 animals received SAH induction.
A detailed overview of animal randomisation is given in Fig. 1.
Depletion of neutrophils, differential leukocyte count, and blood gas analysis. Intraperitoneal 
injection of an antibody directed against the Ly6G antigen, which is expressed by mature neutrophils and tran-
siently by developing monocytes26,27, is an established method for the induction of neutropenia in mice18,19. In 
the neutropenia subgroups assigned for cerebral perfusion measurements or biochemical analysis, an anti-Ly6G 
antibody (InVivoPlus anti-mouse Ly6G, Clone 1A8; BioXCell, West Lebanon, NH, USA) was injected intraperi-
toneally at 40 µg/g body weight in 130 µl 12 h prior to SAH induction, while the corresponding control subgroups 
were injected with 130 µL of normal saline alone.
To analyse the efficacy of neutrophil depletion, blood samples were drawn from the left femoral artery before 
transcardiac perfusion for differential blood cell counting using an automated haematology analyser (ADVIA 
2120; Siemens Healthineers, Erlangen, Germany). Counting and characterisation of murine leukocytes were 
performed using a veterinary software tool (VetMed version 6.3.2; Siemens Healthineers) that accounts for the 
haematological differences among murine species.
Blood gas analysis was performed on blood taken from the left femoral artery using a blood gas analyser (ABL 
800 basic, Radiometer GmbH, Krefeld, Germany).
Murine endovascular filament perforation model of SAH. Subarachnoid haemorrhage was induced 
by endovascular filament perforation under isoflurane anaesthesia (Abbvie, Wiesbaden, Germany) with con-
tinuous ICP monitoring as described previously28–30. Anaesthesia was induced with 4% isoflurane for 1 min 
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and maintained with 2% isoflurane and 40% O2. For analgesia, Buprenorphin (Indivior, Slough, Berkshire, UK; 
0.1 mg/kg body weight) was injected subcutaneously twice daily starting before the induction of SAH. Body tem-
perature was kept constant at 36 °C using a heating pad (Physitemp Instruments LLC, Clifton, NJ, USA).
To induce SAH, anaesthetised mice were placed in the prone position and an ICP probe (Codman, Johnson 
& Johnson, Raynham, MA, USA) was placed through a burr hole in the right frontal region. After surgical prepa-
ration in the supine position, a filament (Prolene 5.0; Ethicon, Norderstedt, Germany) was inserted into the left 
external carotid artery and was advanced intracranially through the internal carotid artery28–30. A sharp rise 
in intracranial pressure was taken as an indicator of successful endovascular perforation. The ICP probe was 
removed at the end of the surgery. Wound closure was performed using Prolene 6.0 sutures (Ethicon). In sham 
animals, this surgical procedure was performed identically but without intracranially advancing the endovas-
cular filament. After surgery, the animals were kept in an incubator heated to 36 °C (IC8000; Draeger, Luebeck, 
Germany) for 1 h to prevent hypothermia.
Determination of cerebral cortical perfusion. Cerebral cortical perfusion was measured before SAH 
or sham surgery as well as 15 min, 3 h, and 24 h after surgery. All measurements were performed under iso-
flurane anaesthesia while keeping the body temperature at 36 °C using a heating pad (Physitemp Instruments 
LLC, Clifton, NJ, USA). Cerebral cortical perfusion was determined using a laser perfusion imager (MoorFLPI-
2-blood flow imager; Cologne, Germany) and analysed with Moor review software (moorFLPI Full-Field Laser 
Perfusion Imager Review Version 4.0) as described28. In brief, the animal was mounted on a stereotaxic frame 
(Stoelting CO., Wood Dale, IL, USA). Following a midline incision to expose the calvaria, 60 transcalvarian per-
fusion images were recorded at 1 picture per second. The wound was then closed with Prolene 6.0 sutures and 
anaesthesia was terminated.
A mean image was calculated from the 60 perfusion images. The mean flux values were determined by evalu-
ating three regions of interest (ROIs), each 2 mm in diameter, placed over the perfusion territory of the left middle 
cerebral artery as shown in Fig. 2. A mean flux value was calculated from the flux values determined over the 
three ROIs. Changes in perfusion are expressed relative to the preoperative flux value.
Determination of 8-iso prostaglandin F2α content in the subarachnoid haematoma. Accumulation 
of 8-iso prostaglandin F2α (8-isoprostane), which is generated by peroxidation of arachidonic acid and arachidonic 
esters in phospholipids, is an established surrogate parameter for oxidative stress31,32. To analyse the effect of neu-
tropenia on oxidative stress levels, 8-isoprostane levels were determined in basal subarachnoid haematomas iso-
lated from mice assigned to the biochemical analysis group. Briefly, the mice were anaesthetised with isoflurane. 
After blood sampling for blood gas analysis and differential leukocyte count, transcardiac perfusion was performed 
with ice-cold Dulbecco’s Phosphate Buffered Saline containing MgCl2 and CaCl2, pH 7.4 (DPBS; Sigma-Aldrich, 
Hamburg, Germany) at 10 mL/min for 90 s. The brain was rapidly removed and immediately transferred to ice-cold 
Figure 1. Overview of animal randomisation and mortality.
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DPBS. After photo documentation of the haematoma location (examples are shown in Fig. 2), the basal subarachnoid 
haematoma was isolated surgically, transferred to a safe-lock tube (Eppendorf, Wesseling-Berzdorf, Germany), and 
immediately shock-frozen in liquid nitrogen. The samples were stored at −80 °C until analysis.
Figure 2. Murine model of subarachnoid haemorrhage. (A,B) Time courses of CPP and ICP changes after 
induction of SAH or sham surgery. Note that ICP increases minutes after SAH induction but returns to near 
baseline after 3 h, leading to a similar CPP as that before induction. (*p < 0.05; error bars indicate SEM; group 
sizes: SAH-neutropenia/cerebral perfusion group 2, n = 7; SAH-control/cerebral perfusion group 4, n = 6; 
sham-neutropenia/cerebral perfusion group 1, n = 4; sham-control/cerebral perfusion group 3, n = 5). (C) 
Representative images of cerebral cortical perfusion before and after induction of SAH in mice receiving vehicle 
or anti-Ly6G antibody to induce neutropenia. (D) Panels 1, 2, and 3 show representative images 15 min, 3 h, and 
24 h after induction of SAH.
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The haematoma samples (approximately 1–2 mg wet weight) were homogenised in 50 μL antioxidant- 
supplemented lysis buffer (100 mM TRIS pH 7.4, 1 mM EDTA, 1 mM DTT, 10 μM phenothiazine) by sonication at 
low intensity for 3 × 5 s on ice33. The homogenates were then centrifuged at 8,000 × g for 10 min at 4 °C to pellet any 
particulate or fibrillar matter and the supernatants were transferred into clean tubes for protein and 8-isoprostane 
determination. The protein content was measured by BCA/copper reduction (Protein Assay Kit from Thermo 
Fisher Scientific, Rockford, IL, USA) and adjusted to 400 µg/mL with lysis buffer. The soluble 8-isoprostane concen-
tration in the adjusted samples was then analysed by competitive enzyme immunoassay (8-isoprostane ELISA Kit; 
Cayman Chemical Company, Ann Arbor, MI, USA) following the manufacturer’s instructions.
Gene expression analysis. RNA was isolated from the left hemispheres of brain samples using a 
Qiagen-RNeasy Plus Universal kit (Qiagen, Hilden, Germany) and reverse-transcribed into cDNA with 
QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer’s instructions. The mRNA quan-
tification by real-time quantitative polymerase chain reaction (qPCR) was performed as described30,34–36. Briefly, 
the cDNA of each sample was amplified using a real-time Lightcycler 480 PCR System (Roche). RT-PCR for 
the detection of cyclophilin A (PPIA), interleukin 1β (IL-1β), tumour necrosis factor α (TNFα), and inducible 
nitric oxide (NO) synthase (iNOS) was carried out using this system30,34–36. Absolute copy numbers of target 
gene mRNA expression were normalised by the absolute number of housekeeping gene copy numbers (PPIA) as 
described previously30,34–36. For normalisation, we used naive brain tissue of 5 C57bl6N mice not included in the 
cerebral perfusion or biochemistry study and which had not undergone any treatment.
statistics. Sigma Plot version 12.5 (Systat Software Inc., San Jose, CA, USA) was used for all statistical anal-
ysis. The data are presented as mean ± standard error of the mean (SEM). Group and subgroup means were 
compared by Mann–Whitney U test or with one-way ANOVA and HolmSidak multiple comparison testing as 
appropriate with p < 0.05 considered statistically significant. Group sizes were based on power analyses with 
Sigma Plot software set with an alpha of 0.05, power of 0.8, and expected group differences in perfusion values 
of 25% ± 13% between the groups based on pilot experiments. These calculations resulted in a group size of 6.
Results
Murine model of SAH. Endovascular filament perforation was followed by a prompt increase in ICP, indi-
cating successful modeling of SAH. Moreover, a subarachnoid haematoma was present in all mice after endovas-
cular filament perforation, whereas no subarachnoid haematomas were found in mice subjected to sham surgery. 
Details on the parameters collected during and after surgery are given in Figs 1 and 2 and in the supplementary 
information.
Intraperitoneal injection of anti-Ly6G antibody induces neutropenia. Intraperitoneal injection of 
the anti-Ly6G antibody significantly reduced total leukocyte and neutrophil counts compared to vehicle injection. 
An evaluation of all 27 animals which received an anti-Ly6G injection to induce neutropenia, and all 26 animals 
which were injected with normal saline is shown in Table 1. Monocyte counts were also reduced by anti-Ly6G 
injection, in agreement with findings that Ly6G is a leukocyte lineage marker expressed during development 
of monocytes as well as by mature neutrophils26,27. In contrast, there were no significant differences in haemo-
globin concentrations or lymphocyte, eosinophil, basophil, and platelet counts between anti-Ly6G-injected and 
vehicle-injected mice, confirming treatment specificity.
Cell counts were also evaluated separately for cerebral perfusion (11 animals with and 11 animals without neu-
tropenia induction by anti-Ly6G injection) and the biochemistry groups (16 animals with and 15 animals without 
neutropenia induction by anti-Ly6G injection). There were also significant differences in cell counts within the 
cerebral perfusion group (total leukocytes, anti-Ly6G: 1.93 ± 0.53/nL vs. vehicle: 3.37 ± 0.51/nL, p < 0.05; neutro-
phils: 0.88 ± 0.46/nL vs. 1.86 ± 0.32/nL, p < 0.05; monocytes: 0.05 ± 0.01/nL vs. 0.21 ± 0.11, p < 0.05) and bio-
chemistry group (leukocytes, anti-Ly6G: 3.27 ± 0.61/nL vs. vehicle: 4.91 ± 0.70/nL, n.s.; neutrophils: 0.41 ± 0.07/nL 
vs. 1.28 ± 0.20/nL, p < 0.001; monocytes: 0.05 ± 0.01/nL vs. 0.13 ± 0.02/nL, p < 0.001). Thus, the effect of anti- 
Ly6G antibody was reproducible and independent of the subsequent treatment.
neutropenia* control* p value
leukocytes/nL 2.74 ± 0.43 4.24 ± 0.47 p < 0.01
neutrophils/nL 0.60 ± 0.19 1.54 ± 0.19 p < 0.001
monocytes/nL 0.05 ± 0.01 0.16 ± 0.05 p < 0.001
lymphocytes/nL 1.73 ± 0.38 2.35 ± 0.44 n. s.
eosinophils/nL 0.09 ± 0.01 0.12 ± 0.02 n. s.
basophils/nL 0.01 ± 0.003 0.01 ± 0.001 n. s.
haemoglobin [g/dL] 14.4 ± 0.3 14.6 ± 0.3 n. s.
platelets/nL 1194 ± 44 1316 ± 63 n. s.
Table 1. Differential leukocyte counts between the control and neutropenia subgroups. *The table summarises 
all blood samples from the cerebral perfusion and the biochemistry groups, i.e., blood samples of 27 animals 
with neutropenia and 26 animals without induction of neutropenia. Data are shown as mean ± SEM.
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SAH enhances the expression of IL-1β, iNos, and tNFα. To examine whether (i.) SAH induced 
expression of inflammation markers and (ii.) whether cerebral inflammation marker expression is susceptible to 
the induction of neutropenia, brain samples of the animals of the biochemistry group sacrificed after 24 h were 
taken to analyse markers of inflammation30,34–36. Compared with naive brain, SAH induction in the absence of 
neutropenia significantly enhanced the tissue expression of all three inflammation markers (IL-1β: 477 ± 99%; 
TNFα: 3978 ± 318%; iNOS: 150 ± 17%).
The induction of neutropenia attenuated the expression of all three inflammation markers, with a differ-
ence that reached statistical significance for iNOS and TNFα (SAH, neutropenia vs. normal neutrophil counts; 
iNOS: 89 ± 13% vs. 150 ± 17%, p < 0.05; IL-1β: 358 ± 98% vs. 477 ± 99%; TNFα: 2542 ± 711% vs. 3978 ± 318%, 
p < 0.05). These results indicate that the induction of neutropenia attenuated cerebral inflammation triggered by 
the induction of SAH (Fig. 3).
Induction of neutropenia improves cerebral cortical hypoperfusion independent of CPP. 
Cerebral cortical perfusion. Cerebral cortical perfusion did not differ between the anti-Ly6G-treated (neutro-
penia) and vehicle-treated (control) subgroups either before or after sham surgery. Further, perfusion values 
did not differ between the vehicle-treated and anti-Ly6G-injected subgroups before SAH induction. In contrast, 
cerebral perfusion was markedly reduced after SAH surgery in the vehicle-injected subgroup compared to the 
vehicle-injected sham subgroup, while the flux values in the anti-Ly6G-injected (neutropenia) SAH subgroup 
were significantly higher than in the vehicle-injected SAH subgroup at 3 h post SAH (99% ± 11% vs. 65% ± 8%, 
p < 0.05). Thus, neutropenia appears to improve hypoperfusion following SAH. Figure 2 presents typical perfu-
sion images in vehicle-treated (control) and anti-Ly6G-injected (neutropenia) subgroup mice. The mean results 
are shown in Fig. 4.
Cerebral perfusion pressure. CPP was calculated as the difference between the mean arterial pressure and the 
ICP determined before the measurements of cerebral perfusion. A significant difference in CPP between the SAH 
and sham mice was observed only at peak ICP immediately after endovascular filament perforation and 15 min 
after induction of SAH, but not before SAH induction or 3 h after. At 24 h after SAH, we observed a higher CPP in 
the sham/vehicle subgroup due to higher mean arterial pressure. The reason for this difference remains unclear. 
CPP did not differ among the other subgroups (Fig. 2). Importantly, CPP did not differ 3 h after SAH between 
neutropenia and vehicle-injected control animals (neutropenia: 64.4 ± 4.8 mmHg vs. control: 60.0 ± 4.2 mmHg), 
so the significant improvement of cerebral perfusion at 3 h after SAH in neutropenic animals was not due to a 
difference in CPP.
Blood gases. Arterial blood samples were taken at the end of the experiments for evaluation of pO2, pCO2, 
and pH. There were no significant differences after induction of neutropenia or saline treatment (pO2, neutro-
penia: 144.7 ± 11.9 mmHg vs. control: 152.0 ± 10.7 mmHg; pCO2, neutropenia: 46.7 ± 1.5 mmHg vs. control: 
44.4 ± 1.6 mmHg; pH, neutropenia: 7.3 ± 0.01 vs. control: 7.3 ± 0.01). Furthermore, blood gas values were similar 
between cerebral perfusion and biochemistry groups, and among the subgroups.
Induction of neutropenia reduces oxidative stress in the subarachnoid haematoma. Animals 
of the biochemistry group were sacrificed 15 min, 3 h, and 24 h after induction of SAH and the 8-isoprostane 
Figure 3. Gene expression of inflammation markers 24 h after SAH. Gene expression of IL-1β (A), iNOS (B), 
TNFα (C) 24 hours after induction of SAH (biochemistry groups 3 (n = 5) and 6 (n = 5), *p < 0.05; **p < 0.01; 
***p < 0.001).
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levels were measured in the basal subarachnoid haematoma as a surrogate parameter of oxidative stress (Fig. 5). 
In the vehicle-treated control subgroup, the 8-isoprostane levels per total protein rose significantly from 15 min 
to 3 hours after SAH and then decreased by 24 h. Induction of neutropenia markedly attenuated the increase in 
8-isoprostane levels between 15 min and 3 h, suggesting that neutrophil accumulation in the haematoma contrib-
utes to oxidative stress.
Figure 4. Enhanced cerebral cortical perfusion after SAH by induction of neutropenia. (A,B) Relative cerebral 
cortical perfusion after induction of SAH or sham surgery. (*p < 0.05; error bars indicate SEM; group sizes: 
SAH-neutropenia/cerebral perfusion group 2, n = 7; SAH-control/cerebral perfusion group 4, n = 6; sham-
neutropenia/cerebral perfusion group 1, n = 4; sham-control/cerebral perfusion group 3, n = 5).
Figure 5. Reduced oxidative stress marker (8-isoprostane) accumulation in the subarachnoid haematoma of 
mice with induced neutropenia. (A) Isolation of the basal subarachnoid haematoma (drawing by Stefan Kindel, 
Mainz, Germany). (B) 8-isoprostane levels in the subarachnoid haematoma after induction of neutropenia or 
vehicle treatment. Note that the significant increase in the 8-isoprostane levels 3 h after SAH in the vehicle group 
was markedly attenuated in the neutropenia group. (*p < 0.05; error bars indicate SEM; group sizes: SAH-
neutropenia (biochemistry groups 1–3): 15 min n = 6, 3 h n = 5, 24 h n = 5 ; SAH-control (biochemistry groups 
4–6): 15 min n = 6; 3 h n = 4; 24 h n = 5).
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Discussion
To the best of our knowledge, this study is the first to investigate the impact of neutrophils on cortical perfusion in 
the initial phase after SAH. In animals subjected to experimental SAH by endovascular filament perforation, neu-
tropenia was associated with significantly improved cerebral cortical perfusion at 3 h post-induction. In addition, 
neutropenia markedly reduced oxidative stress as measured by 8-isoprostane accumulation in the subarachnoid 
haematoma. Taken together, these findings indicate that neutrophils play a major role in cerebral hypoperfusion 
and oxidative stress in the early period after SAH, and strongly suggest that cerebral cortical hypoperfusion dur-
ing the first hours after SAH is dependent on neutrophil-induced cerebral inflammation.
The pathophysiological processes leading to cerebral hypoperfusion in the early hours after SAH are not fully 
understood4–6. As demonstrated in the present and other experimental SAH studies28,30,37–42, subarachnoid bleed-
ing elevates ICP, which in turn reduces CPP. ICP and CPP returned to near baseline levels within 3 hours after 
initial bleeding, in accordance with a report by Westermeier et al.41. However, despite sufficient CPP, cortical 
hypoperfusion persisted in SAH mice with normal neutrophil counts. In contrast, in SAH mice with neutropenia 
cortical perfusion was significantly higher compared to the SAH mice with normal neutrophil counts, indicating 
a role of neutrophils in mediating cerebral hypoperfusion in the hours after SAH.
A decrease in nitric oxide (NO) through NO scavenging appears to be a major mechanism leading to micro-
vascular constriction and cerebral hypoperfusion in the early phase after SAH38,39,43–45. Reduced NO levels 
are believed to be a result of haemolysis and oxidative stress, leading to destructive redox reactions with NO. 
Neutrophil extravasation starts within minutes after SAH24,25. Upon activation, neutrophils release a cocktail of 
redox-active factors, such as myeloperoxidase. This enzyme acts as a potent oxidative stress inducer by generating 
hypochlorous acid46, which reacts with various biomolecules such as NO, leading to a reduction in local NO levels 
and impaired vasorelaxation. Isoprostanes occur after peroxidation of arachidonic acid and arachidonic esters in 
phospholipids under oxidative stress31,32. They were shown to regulate endothelial function and to induce vaso-
constriction47–49. Here we directly demonstrated 8-isoprostane accumulation in the subarachnoid haematoma, 
which, besides the decrease in nitric oxide, may contribute to cortical hypoperfusion.
Cerebral hypoperfusion during the first hours after SAH also occurs in humans8–14. Moreover, these clin-
ical studies showed that the extent of cerebral hypoperfusion early after SAH is strongly associated with DCI 
development and neurological outcome. Improving cerebral hypoperfusion early after SAH could therefore be 
a promising target for new therapeutic approaches. Current treatment strategies aim at optimising haemody-
namic conditions and at controlling metabolic situation and ventilation1–3; however, a causal therapy directly 
modulating the pathomechanisms inducing cerebral hypoperfusion is not available. This study provides new 
pathophysiological data strongly suggesting that oxidative stress induced by neutrophils is a major trigger for 
vasoconstriction resulting in cortical cerebral hypoperfusion early after SAH. Modulation of neutrophil function 
or of neutrophil-induced oxidative stress could be a starting point for new therapies aiming at improving cerebral 
hypoperfusion early after SAH.
Finally, we want to address the limitations of this study. Clinical research data indicate that the degree of 
cerebral hypoperfusion during the first hours after SAH determines the severity of EBI, occurrence of DCI, and 
neurological outcome4,8–14. It would therefore be interesting to examine the effects of neutropenia on DCI and 
long-term neurological outcome. However, in our study, animals were already sacrificed after 15 min to 24 h. 
Therefore, the neutropenia effects on long-term neurological outcome and the incidence of DCI could not be 
analysed. It should be noted, however, that a beneficial long-term effect of neutropenia on vasospasm and neu-
rological outcome has already been shown in a murine SAH model by Provencio et al.18,19. Secondly, neutrophils 
are an essential part of the innate immune system and neutropenia renders a patient susceptible to infections21–23. 
We therefore assume that therapies inducing neutropenia in SAH patients would induce severe complications, 
outweighing the beneficial effects of neutropenia on cerebral hypoperfusion. The approach chosen here to inves-
tigate the pathophysiological mechanisms underlying cerebral cortical hypoperfusion early after SAH is there-
fore not suitable for clinical applications. However, the novel pathophysiological insights on the importance of 
neutrophils may be used as a starting point to develop new therapeutic approaches. Thirdly, injection of the 
anti-Ly6G antibody induced not only neutropenia but also significantly reduced the number of monocytes. This 
fact is in agreement with findings that Ly6G is a leukocyte lineage marker expressed during the development of 
monocytes, as well as by mature neutrophils26,27. Monocytes have been reported to accumulate in the subarach-
noid space two days after SAH50. Conversely, neutrophils have been reported to accumulate within minutes after 
SAH21–23. Although it therefore appears unlikely that monocytes play a major role in mediating cerebral cortical 
hypoperfusion early after SAH, we cannot exclude their contribution.
Conclusion
Neutropenia significantly improved cortical cerebral hypoperfusion and reduced haematoma 8-isoprostane lev-
els, a marker of oxidative stress, in the initial hours after SAH. The data therefore suggest neutrophils as an 
important mediator of cerebral hypoperfusion and oxidative stress in the early period after SAH. Although the 
experimental approach chosen here is not suitable for clinical applications, the findings of this study indicate that 
modulation of neutrophil function and neutrophil-induced oxidative stress could be a promising new approach 
to ameliorate cerebral hypoperfusion in the initial phase after SAH.
Data Availability
The data that support the findings of this study are available from the corresponding authors upon reasonable 
request.
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